Showing results (191-200 of 265) with videos related to

Sort By:
Pageof 27
Journal of Gastroenterology|September 1, 2014
Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressorHisaharu Oya, Mitsuro Kanda, Hiroyuki Sugimoto, et al.
International Journal of Cancer|July 27, 2016
Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancerMitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, et al.
Molecular Cancer Research : MCR|May 23, 2018
Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric CancerHaruyoshi Tanaka, Mitsuro Kanda, Takashi Miwa, et al.
Journal of Hepatology|May 29, 2012
Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse modelsMiloslav Polasek, Bryan C Fuchs, Ritika Uppal, et al.
Current Cancer Drug Targets|November 11, 2010
High therapeutic potential for systemic delivery of a liposome-conjugated herpes simplex virusToshio Shikano, Hideki Kasuya, Tevfik Tolga Sahin, et al.
Nagoya Journal of Medical Science|March 29, 2016
Short-term outcomes after conventional transthoracic esophagectomyYukiko Niwa, Masahiko Koike, Masashi Hattori, et al.
Pancreas|July 21, 2018
Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous NeoplasmsSuguru Yamada, Tsutomu Fujii, Akihiro Hirakawa, et al.
Molecular Therapy Oncolytics|June 14, 2019
Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer GrowthZhiwen Wu, Toru Ichinose, Yoshinori Naoe, et al.
Annals of Surgical Oncology|November 2, 2019
Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic CancerYuki Sunagawa, Suguru Yamada, Yusuke Sato, et al.
Pageof 27